KORU Medical Systems, Inc.
General ticker "KRMD" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $191.5M (TTM average)
KORU Medical Systems, Inc. follows the US Stock Market performance with the rate: 33.1%.
Estimated limits based on current volatility of 1.6%: low 4.02$, high 4.15$
Factors to consider:
- Total employees count: 80 (-2.4%) as of 2024
- US accounted for 81.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Inability to develop new products, Supply chain disruptions, Public health crises, Regulatory and compliance, Product liability
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.97$, 7.79$]
- 2026-12-31 to 2027-12-31 estimated range: [3.71$, 7.37$]
Financial Metrics affecting the KRMD estimates:
- Negative: with PPE of -119.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Inventory ratio change, % of 0.52 <= 0.78
- Positive: -0.02 < Operating cash flow per share per price, % of 0.17
- Positive: -9.55 < Industry operating profit margin (median), % of -3.62
- Negative: negative Net income
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
- Positive: Investing cash flow per share per price, % of -0.34 > -0.60
Short-term KRMD quotes
Long-term KRMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $28.52MM | $33.65MM | $41.13MM |
| Operating Expenses | $38.79MM | $40.09MM | $44.10MM |
| Operating Income | $-10.27MM | $-6.45MM | $-2.97MM |
| Non-Operating Income | $0.50MM | $0.38MM | $0.36MM |
| R&D Expense | $5.74MM | $5.26MM | $4.39MM |
| Income(Loss) | $-9.77MM | $-6.06MM | $-2.62MM |
| Taxes | $3.97MM | $0.00MM | $0.02MM |
| Net Income(Loss)* | $-13.74MM | $-6.07MM | $-2.64MM |
| Stockholders Equity | $20.35MM | $16.81MM | $17.05MM |
| Inventory | $3.48MM | $2.80MM | $3.68MM |
| Assets | $28.46MM | $27.22MM | $28.20MM |
| Operating Cash Flow | $-4.89MM | $-0.32MM | $0.46MM |
| Capital expenditure | $0.81MM | $1.30MM | $0.93MM |
| Investing Cash Flow | $-0.81MM | $-1.33MM | $-0.95MM |
| Financing Cash Flow | $-0.22MM | $-0.25MM | $-0.22MM |
| Earnings Per Share** | $-0.30 | $-0.13 | $-0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.